Nephroptosis, also known as a floating kidney and renal ptosis, is a condition in which the kidney descends more than 2 vertebral bodies (or >5 cm) during a position change from supine to upright. The condition is often treated with nephropexy, a surgical procedure that secures the floating kidney to the retroperitoneum. 
The mobile kidney was first described in the literature by Franciscus de Pedemontanus in the 13th century. Throughout the years, the condition was often left untreated. In 1864, Dietl first characterized the symptoms of acute nephroptosis as episodes of acute abdominal pain and vomiting when the patient was upright. [2, 3] Throughout the 1870s, nephrectomy was used as a treatment option, but it was soon abandoned owing to its excessive morbidity. In 1881, Hahn in Berlin described the first nephropexy in which he affixed the ptotic kidney to the retroperitoneum via the perirenal fat using a lumbar incision.  In 1882, Bassini began using fascial sutures through the renal capsule to affix the ptotic kidney to the retroperitoneum—a procedure that is still in use today. 
The term nephroptosis was first coined by Glenard in 1885. Since then, more than 170 various treatments have been developed for the condition.  Following the developments of anesthesia and antisepsis in the late 19th century, enthusiasm for renal surgery drastically increased; at the end of the 19th century, nephropexy was the most common treatment used to manage nephroptosis by urologists. Many symptoms, including renal pain, lower urinary tract infections, weight loss, gastrointestinal tract issues, anxiety, palpations, and even hysteria were attributed to nephroptosis.  However, because of the inconsistency of diagnosis and symptoms, nephroptosis fell out of favor as an accepted medical diagnosis.
Because of the high postoperative morbidity rate associated with the procedure and the unreliable symptomatic relief in most patients (likely resulting from the wide variation in diagnostic accuracy), nephropexy also fell out of the normal urological repertoire.  A study conducted by Braasch and colleagues in 1948 showed that only 50% of patients who underwent nephropexy to treat nephroptosis achieved symptom resolution. The authors stressed that conservative therapies, such as wearing a corset or resting frequently in a supine position, should be attempted first and that surgical management should be used only in patients with objective obstruction visualized via intravenous urography. In 1984, McWhinnie and Hamilton declared nephropexy to be an “ineffective treatment for [an] imaginary disease”; misdiagnosis and overuse of the procedure had led to its relegation to the dustbin of abandoned surgical procedures. 
However, given modern diagnostic capabilities, it is currently recognized that surgical repair is beneficial in certain symptomatic patients with obstruction of the collecting system or renal blood flow caused by documented renal ptosis.  In 1993, Urban and colleagues at Washington University successfully conducted the first laparoscopic nephropexy.  Subsequently, McDougall and colleagues (2000) further legitimized laparoscopic nephropexy as a valid surgical treatment for nephroptosis by showing improvement in pain conditions in a long-term outcome study. 
Nephroptosis, also known as floating kidney and renal ptosis, is a condition in which the kidney descends more than 2 vertebral bodies (or >5 cm) during a position change from supine to upright. In the upright position, this translocation can lead to symptoms of vomiting and acute abdominal pain due to acute obstruction or ischemia of the kidney.
Nephroptosis is a fairly rare condition, and the number of radiological diagnoses exceeds the number of patients with symptoms attributable to the condition. Many studies have estimated that nearly 20% of women have nephroptosis revealed by routine intravenous urography, but far fewer (10%-20%) actually present with symptoms attributable to the condition. 
Symptomatic nephroptosis is more common in females, with a female-to-male ratio of 5-10:1. In addition, it is more common on the right side (70% of cases).
The cause of nephroptosis is relatively unknown, but there are similarities among most symptomatic patients. Typical cases of nephroptosis usually involve white females who are thin, and it is theorized that a lack of perirenal fat and fascial support can lead to the downward translocation of the kidney. In addition, patients with nephroptosis often present with a longer-than-normal renal vascular pedicle, which allows for renal displacement in the sagittal and frontal axes.  Rarely, nephroptosis may occur in a kidney transplant recipient. 
The current theory attributes the pain in symptomatic nephroptosis to (1) acute hydronephrosis caused by kinking of the proximal ureter caused by the sudden descent of the kidney, (2) lumen narrowing and transient renal ischemia due to elongation of the renal vessels, and/or (3) visceral nerve stimulation due to traction on the renal hilum. 
The typical clinical presentation of symptomatic nephroptosis involves a young (aged 20-40 y) thin woman presenting with costovertebral, flank, or lower-quadrant abdominal pain that occurs in the upright position and that is relieved by lying down and exacerbated by long periods of standing or physical activity. [6, 1] Many patients with the condition may also seek care upon palpating a lower-abdominal mass while in the upright position. 
Risk factors for developing symptomatic nephroptosis include excessive weight loss or frequent extreme physical activity.
The most severe manifestation of symptomatic nephroptosis is Dietl crisis, which is characterized by severe colicky flank pain, nausea, vomiting, chills, tachycardia, oliguria, and transient hematuria or proteinuria due to obstruction.  The pain can be relieved by upward movement of the kidney back to the renal fossa in the supine position and with the head down and feet elevated or in the knee-chest position. 
Pertinent questions in the medical history include the following: 
Is pain exacerbated by standing up from a supine position?
Does severe physical activity exacerbate the pain?
Is the pain alleviated by lying in a supine position?
Have you had significant weight loss in your lifetime?
Have you recently had hematuria, recurrent urinary tract infections, renal calculi, or hypertension?
Can you feel any masses in your lower abdomen on the same side as your pain?
Upon physical examination, at times, the ptotic kidney can be palpated in the ipsilateral lower abdomen when the patient assumes an upright position. The anterior abdominal wall may also show some minor indenting. 
Renal ptosis and renal ectopia can be included on the same differential, as both are inferior renal displacements of greater than 2 vertebral bodies from L2 (right kidney) and 1 cm higher than L2 (left kidney). However, renal ectopia is a permanent congenital displacement of the kidney to this position, and patients with this condition have shorter ureters and an ectopic renal arterial blood supply. Ptotic kidneys have normal-length ureters and renal arteries with a normal origin from the abdominal aorta, whereas an ectopic kidney has a shorter ureter given its fixed interior position. [11, 12]
Other differential diagnoses include the following: 
Renal colic with associated urolithiasis
Cholecystitis (right side)
Intermittent bowel obstruction
Spastic bowel disease
Ovarian vein syndrome
“Nutcracker” syndrome (compression of the left renal vein between the superior mesenteric artery and the abdominal aorta)
Ovarian cystic disease and possible ruptured ovarian cyst
Nephropexy is indicated in a very small percentage of nephroptosis cases. It is reserved only for symptomatic patients with flank pain (often >1 year in duration) in whom studies confirm renal descent upon transition from a supine to an erect position and in whom intravenous urography, renal ultrasonography, or nuclear renal scintigraphy shows delayed excretion and hydronephrosis. 
The kidneys are paired, bean-shaped retroperitoneal organs that sit below the level of the diaphragm. The right kidney is positioned posterior to the liver, and the left is positioned posterior to the spleen. The right renal pelvis traditionally sits at the level of L2, with the left renal pelvis sitting about 1 cm higher, but its normal position can vary from vertebral bodies T12 and L3 (±2 vertebral bodies in both the superior and inferior directions). The kidneys are usually 9-13 cm in length, and the upper portions can be protected by the 11th and 12th ribs. Normally, the posterior side of the kidney contacts the diaphragm superiorly and the vertebral column muscles (psoas major and quadratus lumborum) inferiorly.
The renal parenchyma consists of the renal medulla and cortex, which is surrounded by a fibrous renal capsule. Superficial to the renal capsule that surrounds the kidney is a layer of perirenal fat, and surrounding the perirenal fat is the membranous connective-tissue layer known as the renal (Gerota) fascia. Outside of the renal fascia is the pararenal fat, which is covered by parietal peritoneum anteriorly and transversalis fascia posteriorly.
The kidneys contain a medial fissure called the renal hilum, through which renal vessels, nerves, and the renal pelvis pass. The renal calyces drain into minor infundibula and then into a major infundibulum or directly into a major infundibulum, which then drains into the renal pelvis. The renal pelvis tapers into the ureteropelvic junction inferiorly. The ureter then descends retroperitoneally (on the anterior surface of the psoas major), passing posteriorly to the testicular/ovarian vessels, anteriorly to the bifurcation of the common iliac artery, and distally into the pelvic region.
Ureteral sympathetic afferent nerves travel with the lesser, least, lumbar, and splanchnic nerves, explaining why visceral ureteral pain refers to dermatomes T10 to L2. The renal arteries arise from the abdominal aorta at the level of vertebral body L4, inferior to the origin of the superior mesenteric artery, and superior to the origin of the inferior mesenteric artery. They transverse across the crus of the diaphragm and enter the renal hilum; on the right side, the artery usually travels behind the inferior vena cava before entering the kidney. The renal veins emerge from anterior and posterior sides of the renal pelvis and anastomose at the renal hilum before draining into the inferior vena cava. The left renal vein courses posterior to the pancreas and anterior to the abdominal aorta. The shorter right renal vein courses behind the descending duodenum and the head of the pancreas. 
Nephropexy is contraindicated in asymptomatic nephroptosis.
Winfield H. Nephroptosis. The 5-Minute Urology Consult. Philadelphia: Lippincott Williams and Wilkins; 2000. Vol 1: 368-9.
Dietl J. Wanderende Nieren und deren Einklemmung. Wien Med. Wschr. 1864;14:563 (part I); 1864;14:579 (part II); 1864;14:593 (part III).
Hoenig DM, Hemal AK, Shalhav AL, Clayman RV. Nephroptosis: a “disparaged” condition revisited. Urology. 1999 Oct. 54(4):590-6. [Medline].
Hahn E. Die operative Behandlung der beweglichen Niere durch Fixation. Zentralbl Chirurgie. 1881. 29:449-556.
Barber NJ, Thompson PM. Nephroptosis and nephropexy–hung up on the past?. Eur Urol. 2004 Oct. 46(4):428-33. [Medline].
Bishoff JT, Kavoussi LR. Nephropexy. Campbell-Walsh Urology. Philadelphia: Saunders Elsevier; 2007. 9(2): 1776-8; Ch 51.
Urban DA, Clayman RV, Kerbl K, Figenshau RS, McDougall EM. Laparoscopic nephropexy for symptomatic nephroptosis: initial case report. J Endourol. 1993 Feb. 7(1):27-30. [Medline].
McDougall EM, Afane JS, Dunn MD, Collyer WC, Clayman RV. Laparoscopic nephropexy: long-term follow-up–Washington University experience. J Endourol. 2000 Apr. 14(3):247-50. [Medline].
Plas E, Daha K, Riedl CR, Hubner WA, Pfluger H. Long-term followup after laparoscopic nephropexy for symptomatic nephroptosis. J Urol. 2001 Aug. 166(2):449-52. [Medline].
Dosch AR, Pahl M, Reddy U, Foster CE 3rd, Ichii H. Post-transplantation nephroptosis causing recurrent episodes of acute renal failure and hypertension secondary to intermittent vascular torsion of intraperitoneal renal allograft. J Surg Case Rep. 2017 May. 2017 (5):rjx033. [Medline]. [Full Text].
Friedenberg RM, Harris RD. Techniques and applications of urological imaging. Clinical Urography. Philadelphia: Saunders; 2000. 2(1): 200; Ch 6.
Barth R, Nino-Murcia M, DeVries PA, Friedland GW. Congenital anomalies of the urinary tract. Clinical Urography. Philadelphia: Saunders; 2000. 2(1): 725; Ch 11.
Leonard RJ. Human Gross Anatomy. New York: Oxford University Press; 1995. Vol 1: 119-22.
Nakada SY, McDougall EM, Clayman RV. Laparoscopic Nephropexy. Smith’s Textbook of Endourology. St. Louis: Quality Medical; 1996. 1(2): 945-7; Ch 58.
Tartaglione G, D’Addessi A, De Waure C, Pagan M, Raccioppi M, Sacco E, et al. (99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position. Clin Nucl Med. 2013 Jun. 38(6):432-6. [Medline].
Strohmeyer DM, Peschel R, Effert P, et al. Changes of renal blood flow in nephroptosis: assessment by color Doppler imaging, isotope renography and correlation with clinical outcome after laparoscopic nephropexy. Eur Urol. 2004 Jun. 45(6):790-3. [Medline].
Landman J, McDougall EM, Gill IS, Clayman RV. Retroperitoneum: Nephropexy. Adult and Pediatric Urology. Philadelphia: Lippincott Williams and Wilkins; 2002. 4(1): 707-9; Ch 18.
Fornara P, Doehn C, Jocham D. Laparoscopic nephropexy: 3-year experience. J Urol. 1997 Nov. 158(5):1679-83. [Medline].
Gozen AS, Rassweiler JJ, Neuwinger F, et al. Long-term outcome of laparoscopic retroperitoneal nephropexy. J Endourol. 2008 Oct. 22(10):2263-7. [Medline].
Brenneke HJ, Thiel U. [Nephropexy using tissue adhesive. A 10-year analysis]. Z Urol Nephrol. 1984 Feb. 77(2):107-13. [Medline].
Witter H, Bürger K, Hubner R, Wendt F. [Nephropexy using the tissue adhesive butylcyanoacrylate]. Z Urol Nephrol. 1974 Sep. 67(9):659-65. [Medline].
Hübner WA, Schlarp O, Riedl C, Plas E, Reiter WJ. Laparoscopic nephropexy using tension-free vaginal tape for symptomatic nephroptosis. Urology. 2004 Aug. 64(2):372-4. [Medline].
Vodopija N, Korsic L, Zupancic M, Kramer F, Krstanoski Z, Parac I. Is laparoscopic nephropexy improving the quality of life. Coll Antropol. 2007 Sep. 31(3):689-92. [Medline].
Szekely JG. Re: Laparoscopic nephropexy: Washington University experience. J Urol. 1997 Jan. 157(1):266. [Medline].
Szekely J, Bagheri F, Villa nyi K, Pusztai C, et al. Percutaneous nephropexy with U-tube nephrostomy: long-term follow-up of an alternative technique for treatment of symptomatic nephroptosis. Urology. 2006. 68 (Supplement 5A):227.
Elashry OM, Nakada SY, McDougall EM, Clayman RV. Laparoscopic nephropexy: Washington University experience. J Urol. 1995 Nov. 154(5):1655-9. [Medline].
Ichikawa T, Yamada D, Takao A, Saegusa M, Aramaki K, Kumon H. Retroperitoneoscopic nephropexy for symptomatic nephroptosis. J Endourol. 2003 Nov. 17(9):767-70. [Medline].
Gyftopoulos KI, Fokaefs E, Barbalias GA. The use of the tissue adhesive enbucrilate (histoacryl) in the treatment of symptomatic nephroptosis. Urol Int. 2002. 69(4):313-7. [Medline].
Tunc L, Yesil S, Guneri C, Biri H, Ure I, Bozkirli I. The use of polymer clips in transperitoneal laparoscopic nephropexy. Surg Laparosc Endosc Percutan Tech. 2008 Feb. 18(1):124-6. [Medline].
Arnerlöv C, Söderström M, Öhberg L. Mobile kidney pain provocation ultrasonography before surgery for symptomatic mobile kidney: A prospective study of 43 consecutive patients. Scand J Urol. 2016. 50 (1):61-4. [Medline].
Hubner WA, Schramek P, Pfluger H. Laparoscopic nephropexy. J Urol. 1994 Oct. 152(4):1184-7. [Medline].
Hoenig DM, Hemal AK, Shalhav AL, Clayman RV. Percutaneous nephrostolithotomy, endopyelotomy and nephropexy in a single session. J Urol. 1998 Sep. 160(3 Pt 1):826-7. [Medline].
Samuel G Deem, DO Faculty, Department of Urology, Charleston Area Medical Center
Samuel G Deem, DO is a member of the following medical societies: American College of Surgeons, American Osteopathic Association, American Urological Association, Endourological Society, Society of Urologic Oncology, American Society of Clinical Oncology, American College of Osteopathic Surgeons
Disclosure: Nothing to disclose.
Nathan Hale, DO, MS Resident Physician in Urologic Surgery, Charleston Area Medical Center
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Bradley Fields Schwartz, DO, FACS Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, Society of University Urologists
Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Cook Medical; Olympus.
Edmund S Sabanegh, Jr, MD Chairman, Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation
Edmund S Sabanegh, Jr, MD is a member of the following medical societies: American Medical Association, American Society of Andrology, Society of Reproductive Surgeons, Society for the Study of Male Reproduction, American Society for Reproductive Medicine, American Urological Association, SWOG
Disclosure: Nothing to disclose.
Ralph V Clayman, MD Professor and Chair, Department of Urology Medicine, University of California, Irvine, School of Medicine
Disclosure: Nothing to disclose.
Nick Jain University of California, Irvine, School of Medicine
Disclosure: Nothing to disclose. Elspeth M McDougall, MD, FRCSC, MHPE Professor of Urology, University of California at Irvine Medical Center; Associate Dean, Clinical Science Education and Director, Research in Medical Education, University of California, Irvine School of Medicine
Elspeth M McDougall, MD, FRCSC, MHPE is a member of the following medical societies: American College of Surgeons, American Urological Association, Canadian Urological Association, Endourological Society, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Laparoendoscopic Surgeons, and Society of Women in Urology
Disclosure: Nothing to disclose.
Research & References of Nephroptosis|A&C Accounting And Tax Services